Immunovant Inc.

NASDAQ: IMVT · Real-Time Price · USD
15.96
-0.19 (-1.18%)
At close: May 01, 2025, 3:59 PM
16.39
2.66%
Pre-market: May 02, 2025, 07:00 AM EDT

Immunovant Statistics

Share Statistics

Immunovant has 169.86M shares outstanding. The number of shares has increased by 16.2% in one year.

Shares Outstanding 169.86M
Shares Change (YoY) 16.2%
Shares Change (QoQ) 15.72%
Owned by Institutions (%) 54.54%
Shares Floating 68.32M
Failed to Deliver (FTD) Shares 2.18K
FTD / Avg. Volume 0.12%

Short Selling Information

The latest short interest is 20.83M, so 12.26% of the outstanding shares have been sold short.

Short Interest 20.83M
Short % of Shares Out 12.26%
Short % of Float 23.81%
Short Ratio (days to cover) 7.92

Valuation Ratios

The PE ratio is -16.83 and the forward PE ratio is -5.28. Immunovant's PEG ratio is -1.69.

PE Ratio -16.83
Forward PE -5.28
PS Ratio 0
Forward PS 3.5
PB Ratio 7.07
P/FCF Ratio -20.34
PEG Ratio -1.69
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Immunovant.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 13.7, with a Debt / Equity ratio of 0.

Current Ratio 13.7
Quick Ratio 13.7
Debt / Equity 0
Debt / EBITDA 0
Debt / FCF 0
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-1.25M
Employee Count 207
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 567K
Effective Tax Rate -0.22%

Stock Price Statistics

The stock price has increased by -44.54% in the last 52 weeks. The beta is 0.81, so Immunovant's price volatility has been higher than the market average.

Beta 0.81
52-Week Price Change -44.54%
50-Day Moving Average 17.47
200-Day Moving Average 25.01
Relative Strength Index (RSI) 49.76
Average Volume (20 Days) 1.81M

Income Statement

Revenue n/a
Gross Profit -231K
Operating Income -282.71M
Net Income -259.34M
EBITDA -269.98M
EBIT -270.21M
Earnings Per Share (EPS) -1.88
Full Income Statement

Balance Sheet

The company has 635.37M in cash and 138K in debt, giving a net cash position of 635.23M.

Cash & Cash Equivalents 635.37M
Total Debt 138K
Net Cash 635.23M
Retained Earnings -825.68M
Total Assets 420.93M
Working Capital 344.23M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -214.23M and capital expenditures -360K, giving a free cash flow of -214.59M.

Operating Cash Flow -214.23M
Capital Expenditures -360K
Free Cash Flow -214.59M
FCF Per Share -1.55
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

IMVT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for IMVT is $45, which is 182% higher than the current price. The consensus rating is "Buy".

Price Target $45
Price Target Difference 182%
Analyst Consensus Buy
Analyst Count 10
Stock Forecasts

Scores

Altman Z-Score 16.78
Piotroski F-Score 3